Biosig Technologies (NASDAQ:STEX) and Resolute Holdings Management (NYSE:RHLD) Head to Head Contrast

Biosig Technologies (NASDAQ:STEX) and Resolute Holdings Management (NYSE:RHLD) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings and valuation.

Analyst Ratings

This is a summary of recent recommendations and price targets for Biosig Technologies and Resolute Holdings Management, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biosig Technologies	1	0	1	0	2.00
Resolute Holdings Management	1	0	0	0	1.00

Biosig Technologies presently has a consensus price target of $4.00, suggesting a potential upside of 545.16%. Given Biosig Technologies’ stronger consensus rating and higher possible upside, research analysts plainly believe Biosig Technologies is more favorable than Resolute Holdings Management.

Profitability

This table compares Biosig Technologies and Resolute Holdings Management’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Biosig Technologies	N/A	-462.48%	-307.38%
Resolute Holdings Management	4.21%	3.55%	1.71%

Insider & Institutional Ownership

7.2% of Biosig Technologies shares are held by institutional investors. 52.7% of Biosig Technologies shares are held by insiders. Comparatively, 52.8% of Resolute Holdings Management shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Biosig Technologies and Resolute Holdings Management”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biosig Technologies	$40,000.00	1,805.13	-$462.77 million	($9.05)	-0.07
Resolute Holdings Management	$462.05 million	2.19	-$5.92 million	$5.43	23.88

Resolute Holdings Management has higher revenue and earnings than Biosig Technologies. Biosig Technologies is trading at a lower price-to-earnings ratio than Resolute Holdings Management, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Biosig Technologies has a beta of 2.01, indicating that its share price is 101% more volatile than the S&P 500. Comparatively, Resolute Holdings Management has a beta of -1.31, indicating that its share price is 231% less volatile than the S&P 500.

Summary

Resolute Holdings Management beats Biosig Technologies on 8 of the 14 factors compared between the two stocks.

About Biosig Technologies

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company’s proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

About Resolute Holdings Management

Resolute Holdings Management, Inc. operates as an alternative asset management platform company. The company was incorporated in 2024 and is based in New York, New York.